Neurodevelopmental outcomes of preterm infants treated with bevacizumab for severe retinopathy of prematurity

被引：1
|
作者：
Morin, Julie [1 ]
Superstein, Rosanne [1 ]
Luu, Thuy Mai [1 ,2 ]
Ospina, Luis Humberto [1 ,2 ]
Lefebvre, Francine [1 ,2 ]
Simard, Marie-Noelle [1 ]
Shah, Vibuthi [3 ,4 ]
Shah, Prakesh S. [3 ,4 ]
Kelly, Edmond N. [3 ,4 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
[2] CHU St Justine, Montreal, PQ, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4323
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
    Chang, Yu-Shan
    Chen, Ying-Tin
    Lai, Tso-Ting
    Chou, Hung-Chieh
    Chen, Chien-Yi
    Hsieh, Wu-Shiun
    Yang, Chung-May
    Yeh, Po-Ting
    Tsao, Po-Nien
    PLOS ONE, 2019, 14 (10):
  • [22] Postnatal growth and neurodevelopment of infants treated with bevacizumab for retinopathy of prematurity
    Zhang, David Luowei
    Rahmani, Safa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [23] Spectral-Domain Optical Coherence Tomography of the Macula in Preterm Infants Treated With Bevacizumab for Retinopathy of Prematurity
    Dorta, Paola
    Kychenthal, Andres
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (03): : 321 - 326
  • [24] Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants
    Sjobom, Ulrika
    Hellstrom, William
    Lofqvist, Chatarina
    Nilsson, Anders K.
    Holmstrom, Gerd
    Pupp, Ingrid Hansen
    Ley, David
    Blennow, Kaj
    Zetterberg, Henrik
    Savman, Karin
    Hellstrom, Ann
    JAMA NETWORK OPEN, 2021, 4 (04)
  • [25] Visual acuity and neurodevelopmental outcomes in children with treated retinopathy of prematurity
    Burns, Mason
    Zheng, Linda
    Catt, Caroline
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 1012 - 1013
  • [26] Outcomes in Type I Retinopathy of Prematurity treated with intravitreal bevacizumab
    Mallick, Adnan
    Savoie, Brian
    Lieberman, Ronni M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [27] Outcomes In Type I Retinopathy of Prematurity Treated with Intravitreal Bevacizumab
    Savoie, Brian
    Mallick, Adnan
    Lieberman, Ronni M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [28] Neurodevelopmental Outcomes after Bevacizumab Treatment for Retinopathy of Prematurity A Meta-analysis
    Tsai, Chia-Ying
    Yeh, Po-Ting
    Tsao, Po-Nien
    Chung, Yu-Chu Ella
    Chang, Yu-Shan
    Lai, Tso-Ting
    OPHTHALMOLOGY, 2021, 128 (06) : 877 - 888
  • [29] Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity
    Araz-Ersan, Bilge
    Kir, Nur
    Tuncer, Samuray
    Aydinoglu-Candan, Ozlem
    Yildiz-Inec, Dilbade
    Akdogan, Basri
    Ekici, Baris
    Demirel, Atalay
    Ozmen, Meral
    CURRENT EYE RESEARCH, 2015, 40 (06) : 585 - 591
  • [30] Postnatal Growth Trajectories and Neurodevelopmental Outcomes Following Bevacizumab Treatment for Retinopathy of Prematurity
    Zhang, David L.
    Yoon, Hawke H.
    deRegnier, Raye-Ann O.
    Arzu, Jennifer
    Rahmani, Safa
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 2713 - 2722
12345